Press / media

Together with Leipzig University Hospital and the Helmholtz-Zentrum Dresden-Rossendorf (HZDR), the Fraunhofer Institute for Cell Therapy and Immunology IZI is researching the AI-based development of a tumor-specific CAR T-cell immunotherapy for the treatment of malignant melanoma.

Together, stakeholders from science, business, politics and society have developed a strategy paper to improve the translation of new research findings into medical care applications. The results were presented to Federal Minister of Education and Research, Bettina Stark-Watzinger, at the Futurium in Berlin on 12 June 2024.

On 1 July, the Fraunhofer Institute for Cell Therapy and Immunology and Otto von Guericke University Magdeburg launched a multi-centre confirmatory preclinical study to evaluate the therapeutic effectiveness of a new agent for the treatment of chronic inflammatory bowel diseases.

On 2 May 2024, Reinhard Meyer, minister for economic affairs of Mecklenburg-Vorpommern, presented the awards to the winners of the “Innovative ideas for the healthcare sector” competition, in the state’s capital, Schwerin. The seven winners included a project proposal by Fraunhofer IZI’s Rostock Department of Extracorporeal Therapy. The successful project was “mi4ASSESS-MED – A marketing and innovation strategy to strengthen the market position and competitiveness of ASSESS-MED”.